close

Enter

Log in using OpenID

Ticagrelor Market - Size, Share, Outlook, and Analysis, 2018-2026

embed
Owing to high patient pool suffering from heart problems, increasing generic drug development, and improving market access scenarios.
Ticagrelor Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Ticagrelor Market – Overview
Ticagrelor is used along with aspirin to prevent serious life-threatening problems associated with heart and blood
vessels in people suffering with heart attack or severe chest pain. It is also used to prevent development of blood
clots with coronary stents in patients having history of heart attack or severe chest pain. The global ticagrelor
market is expected to grow at a significant growth rate during the forecast period, owing to high patient pool
suffering from heart problems, increasing generic drug development, and improving market access scenarios.
Increasing burden of heart diseases has direct impact on global morbidity and mortality. For instance, according to
American Heart Association and America Stroke Association report 2017 statistics update, cardiovascular disease
is listed as the underlying cause of death, accounted for nearly 801,000 deaths in 2017, causing about 1 of every 3
deaths in the U.S. Same source also stated that about 92.1 million American adults were living with some form of
cardiovascular disease or the after-effects of stroke in 2017.
Moreover, significant increase in the number of approvals from the U.S. Food and Drug Administration (USFDA)
for ticagrelor will aid in the growth of ticagrelor market during the forecast period. For instance, in July 2018,
USFDA permitted approval for ticagrelor tablets, manufactured by Alembic Pharmaceuticals, to reduce the rate of
cardiovascular deaths and stroke in patients with acute coronary syndrome (ACS), or a history of myocardial
infarction (MI).
REPORT DESCRIPTION
Ticagrelor Market Taxonomy:
Global Ticagrelor Market, By Strength:
60 mg
90 mg
Global Ticagrelor Market, By Indication:
Acute Coronary Syndrome
Ischemic Stroke
Global Ticagrelor Market, By Distribution Channel:
Hospital pharmacies
Retail Pharmacies
Online Pharmacies
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2515
REPORT DESCRIPTION
Ticagrelor Market – Key Players
C.H. Boehringer Sohn AG & Ko. KG
Pfizer
Eli Lilly
AstraZeneca
Natco Pharma Limited
Anhui Haikang Pharmaceutical Co
Avra Laboratories
Sun Pharmaceutical Industries
Europe is also expected to observe significant growth in the global ticagrelor market, owing to increasing
approvals for new ticagrelor formulation development in the region. For instance, in May 2017, the
European Commission granted marketing authorization for AstraZeneca’s Brilique (ticagrelor)
orodispersible tablets (ODT) as a new method of treatment administration. This tablet is effective for
patients with difficulty in swallowing and in emergency cases.
Get More Inf @ https://www.coherentmarketinsights.com/market-insight/ticagrelor-market-2515
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
Author
abhijit
abhijit120   documents Email
Document
Category
Health and Medicine
Views
7
File Size
474 KB
Tags
Ticagrelor Market, ticagrelor, analysis, outlook
1/--pages
Report inappropriate content